Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581984 · ClinicalTrials.gov registry record
McGhan Medical Silicone-Filled Breast Implant Adjunct Study
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 1,016
- Enrollment target
NCT00581984: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00581984 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,016 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00581984 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 1,016 participants
- Enrollment target
Study Summary
This study will collect 5 year data about any possible health problems associated with breast implants. This data will be used to help see if the implants are both safe and effective. If they are proven safe and effective, they will continue to be available. If they are not proven safe and effective to the satisfaction of the FDA, they may not be available in the future.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,016 participants |
| Start Date | 1998-09 |
| Est. Completion | 2013-10 |
What the finished NCT00581984 record still lists
NCT00581984 is an observational study that tracks outcomes without assigning an intervention. Its 1,016 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00581984 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00581984 about?
NCT00581984 is a clinical study titled "McGhan Medical Silicone-Filled Breast Implant Adjunct Study". This study will collect 5 year data about any possible health problems associated with breast implants. This data will be used to help see if the implants are both safe and effective. If they are proven safe and effective, they will continue to be available. If they are not proven safe and effective...
What is the current status of trial NCT00581984?
This trial is currently completed. The enrollment target is 1,016 participants. The study started on 1998-09. Estimated completion is 2013-10.
Who is sponsoring clinical trial NCT00581984?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06608823 · 1,016 participants · NA
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
- NCT06146738 · 1,015 participants
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- NCT06549595 · 1,018 participants · Phase 3
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- NCT02178163 · 1,020 participants · NA
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia